Analog Devices Total Cost of Revenue increased by 6.1% to $1.18B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 15.1%, from $1.03B to $1.18B. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows an upward trend with a 11.0% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $524.77M | $537.67M | $1.22B | $1.28B | $1.03B | $1.07B | $1.10B | $1.13B | $1.12B | $1.11B | $1.07B | $1.04B | $979.00M | $1.00B | $1.03B | $992.87M | $1.03B | $1.09B | $1.13B | $1.12B | $1.18B |
| QoQ Change | — | +2.5% | +126.5% | +5.3% | -19.9% | +3.8% | +3.6% | +1.8% | -0.6% | -0.3% | -4.0% | -2.9% | -5.8% | +2.2% | +2.6% | -3.3% | +3.6% | +6.0% | +4.0% | -1.7% | +6.1% |
| YoY Change | — | — | — | — | +95.8% | +98.4% | -9.3% | -12.2% | +8.8% | +4.5% | -3.2% | -7.7% | -12.5% | -10.2% | -4.0% | -4.4% | +5.1% | +9.0% | +10.4% | +12.3% | +15.1% |
| Segment | Q2 '26 |
|---|---|
| Reportable Segment | $1.18B |
| Total | $1.18B |